Clinical Trial: Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial Pain

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847541) titled 'Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial Pain' on Aug. 04.

Brief Summary: This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effectiveness of botulinum toxin type A (BoNT-A) in patients with temporomandibular myofascial pain who have not improved after at least 3 months of conservative treatment.

Eligible patients aged 18-60 years will be randomly assigned to one of two groups:

* Intervention group: Intramuscular injection of 100 U BoNT-A into the bilateral masseter and temporalis muscles.

* Control group: Intramuscular injection ...